Austrianova, a high-tech, life science and biotech company, headquartered at Centros, Biopolis, Singapore, opened a facility in Thailand Science Park, Bangkok. Austrianova developed the ‘Cell-in-a-Box®’ technology. The technology is for encapsulating living cells in bio-inert polymers and can be used for a variety of purposes in healthcare, biotechnology, probiotics, cosmetics, agricultural and environmental protection and monitoring. The New Lab and GMP Facility in Thailand was opened on December 4th 2014 and the opening ceremony included scientific presentations and a site visit of the custom built facility.
Attendees included representatives from the Thailand Science Park management, the Thai National Science and Technology Development Agency and the Thailand Center of Excellence for Life Sciences (TCELS) as well as guests of honor Mr. Kenneth L. Waggoner (CEO) and Mr. Gerald C. Crabtree (COO) of Nuvilex Inc., and various other Austrianova partners and friends including the Austrian Trade Commission, Betagro, CDIP, Erber AG, Siricell, Mahidol University, King Mongkut’s University of Technology Thonburi and the team from Austrianova Singapore plus some key investors in Austrianova. Mr. Brian Salmons, CEO of Austrianova, stated, “Our new facility includes a unique, state-of-the-art and custom-built, controlled environment isolator for cell production, which we believe to be the first in Asia. This isolator system, housed in a newly built conventional Class D cleanroom, will ensure that all Cell-in-a-Box® products are manufactured according to the highest international pharmaceutical production standards.”
This article is based on materials provided by: http://austrianova.com/category/latest-news/
Disclaimer: This article does not reflect any personal views of the authors/editors